Aeron Michael Small, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 10 | 2024 | 1976 | 1.940 |
Why?
|
Calcinosis | 5 | 2023 | 1499 | 0.990 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 460 | 0.890 |
Why?
|
Aortic Valve | 4 | 2023 | 1934 | 0.730 |
Why?
|
Factor VIII | 1 | 2020 | 356 | 0.620 |
Why?
|
Hemostasis | 1 | 2020 | 460 | 0.610 |
Why?
|
von Willebrand Factor | 1 | 2020 | 672 | 0.560 |
Why?
|
Cardiovascular System | 1 | 2023 | 834 | 0.520 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 568 | 0.520 |
Why?
|
Bone Remodeling | 1 | 2017 | 578 | 0.440 |
Why?
|
Lipid Metabolism | 3 | 2018 | 1883 | 0.430 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 726 | 0.430 |
Why?
|
Peripheral Arterial Disease | 2 | 2020 | 1221 | 0.420 |
Why?
|
Veterans | 3 | 2023 | 2554 | 0.410 |
Why?
|
Data Mining | 1 | 2017 | 543 | 0.410 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3814 | 0.410 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15433 | 0.400 |
Why?
|
Genome-Wide Association Study | 11 | 2024 | 12432 | 0.380 |
Why?
|
Coronary Artery Disease | 3 | 2020 | 6565 | 0.370 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1817 | 0.350 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1229 | 0.340 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 17635 | 0.330 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1901 | 0.310 |
Why?
|
Myocardial Infarction | 2 | 2024 | 11824 | 0.270 |
Why?
|
Phenotype | 3 | 2020 | 16484 | 0.240 |
Why?
|
Alcohol Dehydrogenase | 2 | 2021 | 119 | 0.220 |
Why?
|
Dyslipidemias | 2 | 2023 | 865 | 0.220 |
Why?
|
Chromosomes, Human, Y | 1 | 2023 | 148 | 0.210 |
Why?
|
Atherosclerosis | 3 | 2024 | 3480 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2023 | 15657 | 0.180 |
Why?
|
Mosaicism | 1 | 2023 | 442 | 0.180 |
Why?
|
Glycerophospholipids | 1 | 2020 | 36 | 0.180 |
Why?
|
Fatty Acid Desaturases | 1 | 2020 | 102 | 0.180 |
Why?
|
Alcoholism | 2 | 2021 | 1936 | 0.170 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 642 | 0.170 |
Why?
|
Osteoprotegerin | 1 | 2020 | 176 | 0.170 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 999 | 0.160 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2018 | 55 | 0.160 |
Why?
|
Osteopontin | 1 | 2020 | 301 | 0.160 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 500 | 0.160 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 380 | 0.150 |
Why?
|
Electronic Health Records | 3 | 2020 | 4579 | 0.150 |
Why?
|
Risk Factors | 8 | 2024 | 73094 | 0.150 |
Why?
|
Secondary Prevention | 1 | 2024 | 1553 | 0.150 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 543 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 79 | 0.140 |
Why?
|
Lipids | 2 | 2018 | 3326 | 0.140 |
Why?
|
Heart Diseases | 2 | 2019 | 2802 | 0.140 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1077 | 0.130 |
Why?
|
Humans | 28 | 2024 | 752741 | 0.130 |
Why?
|
Glycoproteins | 1 | 2023 | 2253 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1236 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2020 | 2385 | 0.120 |
Why?
|
Cholesterol | 1 | 2023 | 2926 | 0.120 |
Why?
|
Aged | 11 | 2024 | 165629 | 0.110 |
Why?
|
Monocytes | 1 | 2023 | 2602 | 0.110 |
Why?
|
Genetic Loci | 2 | 2020 | 2614 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2020 | 21904 | 0.100 |
Why?
|
Fatty Liver | 1 | 2018 | 736 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2017 | 866 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1439 | 0.100 |
Why?
|
Risk | 2 | 2020 | 9683 | 0.100 |
Why?
|
Male | 12 | 2024 | 354311 | 0.090 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14219 | 0.090 |
Why?
|
Polysaccharides | 1 | 2016 | 1050 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1264 | 0.090 |
Why?
|
Hemodynamics | 1 | 2019 | 4216 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3618 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5851 | 0.080 |
Why?
|
Female | 12 | 2024 | 385090 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3998 | 0.070 |
Why?
|
Genomics | 2 | 2021 | 5743 | 0.070 |
Why?
|
Genetic Variation | 2 | 2019 | 6567 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11909 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3715 | 0.070 |
Why?
|
DNA | 1 | 2020 | 7312 | 0.070 |
Why?
|
Stroke Volume | 1 | 2019 | 5103 | 0.070 |
Why?
|
Disease Progression | 2 | 2019 | 13364 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7152 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
Obesity | 2 | 2023 | 12868 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14761 | 0.060 |
Why?
|
Cohort Studies | 2 | 2024 | 40939 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12165 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 6083 | 0.050 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2021 | 23 | 0.050 |
Why?
|
Inflammation | 2 | 2023 | 10751 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15657 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2023 | 315 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15164 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20026 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29264 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9300 | 0.040 |
Why?
|
Genotype | 3 | 2020 | 12970 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10422 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23554 | 0.040 |
Why?
|
Receptors, Dopamine D2 | 1 | 2021 | 475 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 180 | 0.040 |
Why?
|
Middle Aged | 7 | 2020 | 216054 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11096 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2019 | 480 | 0.040 |
Why?
|
Algorithms | 1 | 2017 | 13984 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 417 | 0.030 |
Why?
|
Asia | 1 | 2017 | 612 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2018 | 595 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58361 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1893 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1830 | 0.030 |
Why?
|
Adiposity | 1 | 2023 | 1823 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1593 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 780 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 29981 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2160 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1747 | 0.030 |
Why?
|
Adult | 3 | 2020 | 216658 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3359 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2019 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4327 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5124 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6954 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 12769 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2017 | 2559 | 0.020 |
Why?
|
Animals | 2 | 2017 | 169600 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5965 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8413 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2755 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5367 | 0.020 |
Why?
|
Sepsis | 1 | 2019 | 2604 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6118 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10914 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 13011 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4692 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12202 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9223 | 0.010 |
Why?
|
Smoking | 1 | 2020 | 9030 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10450 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7538 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29630 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18174 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40195 | 0.010 |
Why?
|
HIV Infections | 1 | 2020 | 16882 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81766 | 0.010 |
Why?
|